AmerisourceBergen has signed a definitive agreement to sell its Canadian pharmaceutical distribution business, AmerisourceBergen Canada (ABCC), to Canadian-owned national full-line distributor Kohl & Frisch.
The estimated sale price is expected to be between $80m and $100m, of which approximately half will be financed by AmerisourceBergen.
ABCC represents approximately 2% of AmerisourceBergen's total revenues.
AmerisourceBergen, however, will retain its Canadian specialty business.
The transaction, which is subject to customary closing conditions, is likely to close in the third quarter of fiscal 2013.
Source:
http://inwardinvestment.pharmaceutical-business-review.com/news/amerisourcebergen-to-sell-canadian-pharmaceutical-distribution-business-010413
